| Date Filed | Type | Description |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 5 shares
@ $1.3, valued at
$6.5 |
|
| 01/10/2023 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 11 shares
@ $1.3, valued at
$14.3 |
|
| 01/04/2023 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 5 shares
@ $1.89, valued at
$9.5 |
|
| 01/04/2023 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 3 shares
@ $1.89, valued at
$5.7 |
|
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 4 shares
@ $2.2392, valued at
$9 |
|
| 11/08/2022 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 10 shares
@ $2.2392, valued at
$22.4 |
|
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 9 shares
@ $2.72, valued at
$24.5 |
|
| 10/11/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 4 shares
@ $2.72, valued at
$10.9 |
|
| 10/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 5 shares
@ $2.08, valued at
$10.4 |
|
| 09/07/2022 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 225 shares
@ $0.1566, valued at
$35.2 |
|
| 09/07/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 89 shares
@ $0.1566, valued at
$13.9 |
|
| 09/01/2022 |
4
| Schroeder Theodore R (CEO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 107 shares
@ $0.1646, valued at
$17.6 |
|
| 09/01/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 61 shares
@ $0.1646, valued at
$10 |
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Exercised 93,400 options to buy
@ $0.45, valued at
$42k
Exercised 46,700 restricted stock units
@ $0
Exercised 93,400 rights
@ $0.45, valued at
$42k
Exercised 46,700 options to buy
@ $0 |
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Dolan Daniel (CFO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Exercised 83,200 options to buy
@ $0.45, valued at
$37.4k
Exercised 41,600 restricted stock units
@ $0
Exercised 83,200 rights
@ $0.45, valued at
$37.4k
Exercised 41,600 options to buy
@ $0 |
|
| 08/15/2022 |
4
| Guico-Pabia Christine J. (Chief Medical Officer) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Exercised 71,500 options to buy
@ $0.45, valued at
$32.2k
Exercised 35,700 restricted stock units
@ $0
Exercised 71,500 rights
@ $0.45, valued at
$32.2k
Exercised 35,700 options to buy
@ $0 |
|
| 08/08/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Paid exercise price by delivering 89 shares
@ $0.1847, valued at
$16.4 |
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 8,496 shares
@ $0.175, valued at
$1.5k
|
|
|